AMP maintains the following list of resources as a service to our membership and the molecular laboratory community. Check back often - this page will update when new information becomes available.
FDA Rule compliance stage-specific resources are sorted by stage below; resources may appear in multiple sections. AMP does NOT certify that the information contained within the linked external resource pages is complete, accurate, and/or free of commercial bias. By clicking on an external resource link below, you will leave the AMP website. If you identify an additional resource for inclusion or find a broken link, please contact us. *Member-only resource $May require purchaseQuick links to sections below
AMP Members, use the CHAMP community when you have questions for your AMP colleagues Visit CHAMP
AMP Resource Center on the FDA Final Rule on LDTs
Q & A WITH THE FDA
Site-specific questions? Contact LDTFinalRule@fda.hhs.gov, licensed counsel, and/or certified regulatory affairs professionals.
SUBMIT POLICY / REGULATORY QUESTIONS
SUBMIT LABORATORY PRACTICE / COMPLIANCE QUESTIONS
Questions sent to FDA: (updated 9/30/2024)
Policy / regulatory - TBD
Laboratory practice / compliance – TBD
Replies from the FDA: (updated 9/30/2024)
Policy / regulatory - TBD
Laboratory practice / compliance – TBD
WEBINARS
5/9/2024: Final Rule: FDA Rule Medical Device; Laboratory Developed Tests Slides
9/16/2024: A Discussion on the Recent AMP Lawsuit Filing Slides
Federal Register - Medical Devices; Laboratory Developed Tests (FDA Final Rule, 5/6/2024)
Code of Federal Regulations (CFR) Title 21 Part 803 -- MEDICAL DEVICE REPORTING key terms are defined
Final Rule on Electronic Medical Device Reporting (eMDR)
Proposed Rule: Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices (9/25/2024)
DOCUMENTS (see stages below for additional resources)
Navigating FDA’s LDT Final Rule: Key Terminology Every Clinical Lab Should Know (Today’s Clinical Lab)
WEBINARS (see stages below for additional resources)
Regulatory Education for Industry (REdI) Annual Conference 2024 (5/29-30/2024)
CDRH (Devices) Innovation in Medical Product Development (Day 1 of 2)
CDRH (Devices) Innovation in Medical Product Development (Day 2 of 2)
Professional Association Sponsored
The U.S. Food and Drug Administration’s rule on laboratory developed tests — What it means for you (ADLM)
Assorted sponsors
Wherever possible, FDA guidance is sorted on this webpage by the applicable FDA Rule compliance stage
FDA MEDICAL DEVICE WEBSITES AND ONLINE RESOURCES
FDA FINAL RULE: Federal Register - Medical Devices; Laboratory Developed Tests (5/6/2024)
Laboratory Developed Tests (LDTs)
Medical Device Reporting (MDR): How to Report Medical Device Problems
FDA CDRH Events (including webinars)
Total Product Life Cycle Advisory Program (TAP)
FDA WEBINARS
5/14/2024: Final Rule: Medical Devices; Laboratory Developed Tests
7/16/2024: In Vitro Diagnostic Product (IVD): Classification
10/24/2024: FDA’s Total Product Lifecycle Approach to In Vitro Diagnostic Products
FDA PUBLISHED GUIDANCE DOCUMENTS
Laboratory Developed Tests: Frequently Asked Questions
Laboratory Developed Tests: Small Entity Compliance Guide
FDA MEDICAL DEVICE DATABASES
Establishment Registration & Device Listing
Recognized Consensus Standards: Medical Devices
Search for FDA Guidance Documents
Clinical Laboratory Improvement Amendments (CLIA)
Device Classification Under Section 513(f)(2)(De Novo)
Manufacturer and User Facility Device Experience (MAUDE) Database
CDRH Export Certificate Validation (CECV)
CDRH FOIA Electronic Reading Room
CFR - Code of Federal Regulations Title 21
Humanitarian Device Exemption (HDE)
Medical Product Safety Network (MedSun) Reports
522 Postmarket Surveillance Studies
Total Product Life Cycle (TPLC)
FDA MEDICAL DEVICE WEBSITES AND ONLINE RESOURCES
FDA CDRH Events (including webinars)
Total Product Life Cycle Advisory Program (TAP)
Coronavirus (COVID-19) and Medical Devices
Definitions and General Oversight: Laboratory Developed Tests FAQs
Specific Test Categories or Technologies: Laboratory Developed Tests FAQs
Phaseout Policy and Enforcement Discretion Policies: Laboratory Developed Tests FAQs
Premarket Review: Laboratory Developed Tests FAQs
Resources and Interactions with FDA: Laboratory Developed Tests FAQs
Labeling: Laboratory Developed Tests FAQs
Investigational Use: Laboratory Developed Tests FAQs
FDA PUBLISHED GUIDANCE
8/22/2024 Draft Guidance: Predetermined Change Control Plans for Medical Devices
Proposed Rule: Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices (9/25/2024)
FDA WEBINARS / CDRH LEARN MODULES
5/20/24: Laboratory Developed Tests; Medical Devices: Final Rule Slides Transcript
An Introduction to FDA's Regulation of Medical Devices Slides Transcript
How is CDRH Structured? Slides Transcript
Is My Product a Medical Device? Slides Transcript
An Introduction to the Medical Device User Fee Program: MDUFA V Slides Transcript
Standards
Module 5: The ASCA Pilot: Streamlining Conformity Assessment in Device Submissions Slides Transcript
Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program - Final Guidances Slides Transcript
Cross-Cutting Premarket Policy
Combination Product Updates for "Acceptance and Filing Reviews for Premarket Approval Applications" and "Refuse to Accept Policy for 510(k)s" Slides Transcript
Consideration of Uncertainty in Making Benefit-Risk Determinations in Medical Device Premarket Approvals, De Novo Classifications, and Humanitarian Device Exemptions Slides Transcript
Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications Slides Transcript
Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices Slides Transcript
Safer Technologies Program: Draft Guidance Slides
Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices Slides Transcript
510(k) Third Party Review Program (intended for Third Party Review Programs)
510(k) Third Party Review Program: Final Guidance510(k) Third Party Review Program: Final Guidance Slides Transcript
De Novo
DOCUMENT RESOURCES
Navigating FDA’s LDT Final Rule: Key Terminology Every Clinical Lab Should Know (Today’s Clinical Lab)
Summary and analysis of Food and Drug Omnibus Reform Act of 2022 (Hyman, Phelps & McNamara, P.C.)
ONLINE RESOURCES
ADDITIONAL WEBINARS
Professional Association sponsored
The U.S. Food and Drug Administration’s rule on laboratory developed tests — What it means for you (ADLM)
Assorted sponsors
Mandatory Reporting Requirements: Manufacturers, Importers and Device User Facilities, last accessed 9/19/2024
FDA MedWatch Form 3500A Supplement – General Instructions for Form 3500A
FDA MEDICAL DEVICE WEBSITES AND ONLINE RESOURCES
FDA Electronic Submissions Gateway (ESG)
For assistance with the registration or testing process, contact?ESGHelpDesk@fda.hhs.gov?
ESG User Portal (https://esgportal.fda.gov/)
WebTrader Test website:https://esgtest.fda.gov/
ESG WebTrader Production application: https://esg.fda.gov/
Mandatory Reporting Requirements: Manufacturers, Importers and Device User Facilities
Options for manufacturers and importers to electronically submit Medical Device Reporting (MDRs):
Web Interface using the eSubmitter application
AS2 Gateway-to-Gateway using HL7 ICSR XML
Medical Device Reporting (MDR) - Contact Information for User Facilities and Manufacturers
FDA Manufacturer and User Facility Device Experience (MAUDE) database
Reporting Allegations of Regulatory Misconduct
Allegations of Regulatory Misconduct Form
CDRH FOIA: How to Get Records from CDRH
Appendix G: Letters of Non-Repudiation Agreement
Voluntary Malfunction Summary Reporting Program webpage
Exemptions, Variances, and Alternative Forms of Adverse Event Reporting for Medical Devices
FDA PUBLISHED GUIDANCE
Code of Federal Regulations (CFR) Title 21 Part 803 -- MEDICAL DEVICE REPORTING key terms are defined
Final Rule on Electronic Medical Device Reporting (eMDR)
Recalls, Corrections and Removals (Devices)
FDA WEBINARS / CDRH LEARN MODULES
Complaint Files (presentation)
Registration and Listing
Medical Device Reporting (MDR)
Medical Device Recalls
Electronic Submission of 806 Reports of Corrections and Removals Slides
Inspections - Global Harmonization
(1A) Introduction to the MDSAP Program Slides Transcript
(1B) Overview of the MDSAP Audit Process Slides Transcript
(2) MDSAP: Management Process Slides Transcript
(3) MDSAP: Device Marketing Authorization and Facility Registration Slides Transcript
(4) MDSAP: Measurement, Analysis and Improvement Process Slides Transcript
(5) MDSAP: Medical Device Adverse Events and Advisory Notices Reporting Process Printable Slides Transcript
(6) MDSAP: Design and Development Process Slides Transcript
(7) MDSAP: Production and Service Controls Process, Part 1 Slides Transcript
(8) MDSAP: Production and Service Controls Process: Part 2 Slides Transcript
(9) MDSAP: Production and Service Controls Process: Part 3 Slides Transcript
(10) MDSAP: Purchasing Process Slides Transcript
QUESTIONS ABOUT MEDICAL DEVICE REPORTING, including interpretation of MDR policy
Call: (301) 796-6670 | Email:?MDRPolicy@fda.hhs.gov |
Or write to: |
Food and Drug Administration, Center for Devices and Radiological Health, MDR?Reporting Team, 10903 New Hampshire Avenue, WO Bldg. 66, Room 3217, Silver Spring, MD 20993-0002 |
DOCUMENT RESOURCES
Navigating FDA’s LDT Final Rule: Key Terminology Every Clinical Lab Should Know (Today’s Clinical Lab)
ONLINE RESOURCES
ADDITIONAL WEBINARS
Understanding Post-Market Surveillance (PMS) for Medical Devices
FDA WEBSITES AND ONLINE RESOURCES
FDA Establishment Registration & Device Listing Database
Labeling: Laboratory Developed Tests FAQs
Investigational Use: Laboratory Developed Tests FAQs
FDA PUBLISHED GUIDANCE
Device Registration and Listing
In Vitro Diagnostic Device Labeling Requirements
Investigational?Device Exemption (IDE) | FDA
Proposed Rule: Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices (9/25/2024)
FDA WEBINARS / CDRH LEARN MODULES
9/24/2024: Labeling Requirements for In Vitro Diagnostic Products (IVD), including LDTs, Under 21 CFR 809.10(b)
Clinical Studies/Investigational Device Exemption (IDE)
Implementation of Final Rule on Human Subject Protection: Acceptance of Data from Clinical Investigations for Medical Devices Slides Survey
An Update on the FDA's Medical Device Clinical Trials Program Slides (Full, Part 1, Part 2) Transcript
IDEs for Early Feasibility Medical Device Clinical Studies, Including First in Human (FIH) Studies Slides Transcript
FDA Guidance: Design Considerations for Pivotal Clinical Investigations for Medical Devices Slides Transcript
Final Guidance on "Evaluation and Reporting of Age, Race, and Ethnicity Data in Medical Device Clinical Studies" Slides Transcript
Post-Approval Study Requirements and Postmarket Surveillance under Section 522 of the Federal Food, Drug, and Cosmetic Act, Final Guidances Slides Transcript
FDA Categorization of Investigational Device Exemption (IDE) Devices to Assist the Centers for Medicare and Medicaid Services (CMS) with Coverage Decisions Slides Transcript
Humanitarian Use Device (HUD)/Humanitarian Device Exemption (HDE)
HDE Module 3: Humanitarian Device Exemption (HDE): Program Overview and Pre-approval Activities Slides Transcript
DOCUMENT RESOURCES
Navigating FDA’s LDT Final Rule: Key Terminology Every Clinical Lab Should Know (Today’s Clinical Lab)
ONLINE RESOURCES
ADDITIONAL WEBINARS
FDA PUBLISHED GUIDANCE
QS Regulation/Medical Device Current Good Manufacturing Practices (CGMP)
WEBINARS / CDRH LEARN MODULES
Overview of the Quality System (Start here!)
Quality Management System Regulation (8/30/24)
Exports and Imports
General Policy
Notifying CDRH of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act During the COVID-19 Public Health Emergency Slides Transcript
Final Guidance: Factors to Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance and Enforcement Decisions Slides Transcript
Computer Software Assurance for Production and Quality System Software, Draft Guidance Slides Transcript
FDA RECOGNIZED STANDARDS (not an exhaustive list)
CLSI$
CLSI QMS23 General Laboratory Equipment Performance Qualification, Use, and Maintenance, 2nd Edition
CLSI POCT07 Quality Management: Approaches to Reducing Errors at the Point of Care, 1st Edition FREE for a limited time
CLSI EPLDT Quick Guide Validating Performance Claims for Laboratory-Developed Tests, 1st Edition FREE
ISO Documents$
OTHER WEBINARS
CLSI Quality Management Systems webinars (multiple)
Unpacking FDA Guidance: Quality System Considerations and Content of Premarket Submissions
QSR to QMSR: The Rewrite of 21 CFR Part 820 & Key Considerations for FDA Compliance (Greenlight Guru)
DOCUMENT RESOURCES
Navigating FDA’s LDT Final Rule: Key Terminology Every Clinical Lab Should Know (Today’s Clinical Lab)
ONLINE RESOURCES
CLSI$
ADDITIONAL WEBINARS
FDA WEBSITES AND ONLINE RESOURCES
FDA Device Classification Database
Definitions and General Oversight: Laboratory Developed Tests FAQs
Specific Test Categories or Technologies: Laboratory Developed Tests FAQs
Phaseout Policy and Enforcement Discretion Policies: Laboratory Developed Tests FAQs
Premarket Review: Laboratory Developed Tests FAQs
Resources and Interactions with FDA: Laboratory Developed Tests FAQs
FDA PUBLISHED GUIDANCE
Premarket Submissions: Selecting and Preparing the Correct Submission | FDA
Deciding When to Submit a 510(k) for a Change to an Existing Device
8/22/2024 Draft Guidance: Predetermined Change Control Plans for Medical Devices
Proposed Rule: Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices (9/25/2024)
FDA WEBINARS / CDRH LEARN MODULES
Risk Basics for Medical Devices
Application of Risk Management Principles for Medical Devices
6/11/2024: Enforcement Policies for Certain In Vitro Diagnostic Devices - Draft Guidances Slides Transcript
8/18/2024: In Vitro Diagnostic Product (IVD): Classification Slides Transcript
Classification
Final Guidance on Medical Device Accessories: Describing Accessories and Classification Pathway for New Accessory Types Slides Transcript
Premarket Approval Application (PMA)
Premarket Notification (510k)
Safety and Performance Based Pathway Criteria for Certain Device Types Final Guidances Slides Transcript
Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications (510(k)) with Different Technological Characteristics Slides Transcript
Final Guidances on "Deciding When to Submit a 510(k) for a Change to an Existing Device" and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" Slides Transcript
Q-Submissions
Cross-Cutting Premarket Policy
Combination Product Updates for "Acceptance and Filing Reviews for Premarket Approval Applications" and "Refuse to Accept Policy for 510(k)s" Slides Transcript
Consideration of Uncertainty in Making Benefit-Risk Determinations in Medical Device Premarket Approvals, De Novo Classifications, and Humanitarian Device Exemptions Slides Transcript
Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications Slides Transcript
Leveraging Existing Clinical Data for Extrapolation to Pediatric Uses of Medical Devices Slides Transcript
Safer Technologies Program: Draft Guidance Slides
Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices Slides Transcript
De Novo
DOCUMENT RESOURCES
Navigating FDA’s LDT Final Rule: Key Terminology Every Clinical Lab Should Know (Today’s Clinical Lab)
ONLINE RESOURCES
ADDITIONAL WEBINARS
LDT vs IVD: Adapting to the New FDA Regulations (MCRA)
Understanding the FDA Pre-Market Approval (PMA) Process for Medical Devices (eLeap)
10 Steps to Preparing Your 510(k) Submission (and How to Avoid the Common Pitfalls) (Greenlight Guru)
Unpacking FDA Guidance: Quality System Considerations and Content of Premarket Submissions
Only laboratories that hold a New York State clinical laboratory permit are authorized to perform testing on specimens originating from New York. Review of LDT begins after the clinical laboratory permit application has been submitted. LDT review is not offered as a stand-alone service.
NYSDOH RESOURCES
Obtain a NYS Clinical Laboratory Permit
Certificate of Qualification & Laboratory Director Requirements
Application Procedures for Test Approval
Tiered Evaluation of Laboratory Developed Tests Policy
DOCUMENT RESOURCES
Sept 2024: NYS Clinical Laboratory Association Newsletter – FDA’s Final Rule Regulating LDTs (Jane Pine Wood)
FDA MEDICAL DEVICE WEBSITES AND ONLINE RESOURCES
09/27/2023: Final Guidance: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices
FDA Digital Health and Artificial Intelligence Glossary – Educational Resource
Playbook for Threat Modeling Medical Devices
1/02/2023: Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions
Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks (FDA via contract with MITRE)
Software as a Medical Device (SaMD)
Artificial Intelligence and Machine Learning in Software as a Medical Device website
Listing of Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices
Good Machine Learning Practice for Medical Device Development: Guiding Principles
Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices: Guiding Principles
Guidances with Digital Health Content
Cybersecurity in Medical Devices Frequently Asked Questions (FAQs)
Your Clinical Decision Support Software: Is It a Medical Device?
FDA WEBINARS / CDRH LEARN MODULES
Changes to Existing Medical Software Policies Resulting from Section 3060 of the 21st Century Cures Act: Final Guidance Slides Transcript
Clinical Decision Support Software, Final Guidance Transcript
Content of Premarket Submissions for Device Software Functions, Final Guidance Slides Transcript
Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions - Final Guidance Slides Transcript
Design Considerations and Premarket Submission Recommendations for Interoperable Medical Devices Final Guidance Slides Transcript
Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions Slides Transcript
Postmarket Management of Cybersecurity in Medical Devices Final Guidance? Slides Transcript
5/9/2024: Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the FD&C Act, Draft Guidance Slides Transcript
FDA MEDICAL DEVICE WEBSITES AND ONLINE RESOURCES
Definitions and General Oversight: Laboratory Developed Tests FAQs
Specific Test Categories or Technologies: Laboratory Developed Tests FAQs
Phaseout Policy and Enforcement Discretion Policies: Laboratory Developed Tests FAQs
Premarket Review: Laboratory Developed Tests FAQs
Resources and Interactions with FDA: Laboratory Developed Tests FAQs
Labeling: Laboratory Developed Tests FAQs
Investigational Use: Laboratory Developed Tests FAQs
FDA PUBLISHED GUIDANCE
Proposed Rule: Microbiology Devices; Reclassification of Antigen, Antibody, and Nucleic Acid-Based Hepatitis B Virus Assay Devices (9/25/2024)
FDA WEBINARS / CDRH LEARN MODULES
See STAGE 3 section above - FDA Webinars / CDRH Learn Modules about QSR / QMSR
Standards
FDA RECOGNIZED STANDARDS FOR MOLECULAR TESTING (not an exhaustive list)
CLSI$
CLSI MM14 Design of Molecular Proficiency Testing/External Quality Assessment, 2nd Edition FREE for a limited time
CLSI EPLDT Quick Guide Validating Performance Claims for Laboratory-Developed Tests, 1st Edition FREE
CLSI GP36 Planning for Laboratory Operations During a Disaster, 1st Edition FREE for a limited time
CLSI POCT07 Quality Management: Approaches to Reducing Errors at the Point of Care, 1st Edition FREE for a limited time
CLSI POCT18 Selection Process for CLIA-Waived Testing for SARS-CoV-2, Respiratory Syncytial Virus, and Influenza Viruses, 1st Edition FREE for a limited time
ISO$
DOCUMENT RESOURCES
Navigating FDA’s LDT Final Rule: Key Terminology Every Clinical Lab Should Know (Today’s Clinical Lab)
ONLINE RESOURCES
CLSI$
Assorted sponsors
10 Steps to Preparing Your 510(k) Submission (and How to Avoid the Common Pitfalls) (Greenlight Guru)
Disclaimer: With the exception of resources labeled above as having been generated by AMP, links will take you to external websites. Resources above are the sole responsibility of the entity providing them. AMP does not endorse any commercial product or service. AMP makes no warranty, express or implied, regarding any commercial product or service, and hereby disclaims, the accuracy, completeness, timeliness or merchantability or fitness for a particular purpose of the content and associated materials presented above. AMP shall not be liable for any damages, including direct, indirect, special, incidental, or consequential or any other type of damages arising out of or related to the use of the information contained on this page or associated materials.